Clinical Case Report

Selenium deficiency in mineral-rich mid-Western Australia


Venkata Kodali1 Associate Professor, Consultant Physician/Endocrinologist *


* Venkata Kodali


1 Sir Charles Gairdner Hospital and University of Western Australia, 51-85 Shenton Street, Geraldton, WA 6530, Australia


27 April 2018 Volume 18 Issue 2


RECEIVED: 3 February 2017

REVISED: 6 July 2017

ACCEPTED: 19 July 2017


Kodali V.  Selenium deficiency in mineral-rich mid-Western Australia. Rural and Remote Health 2018; 18: 4350. https://doi.org/10.22605/RRH4350


© Venkata Kodali 2018 A licence to publish this material has been given to James Cook University, jcu.edu.au


Context:  Selenium is an essential micronutrient for human beings. Selenoproteins play a role in anti-oxidation and in maintaining immunity. Selenoproteins are distributed in all tissues, the most important of which are glutathione peroxidase, thioredoxin reductase and deiodinases. The deiodinases are selenium-dependent enzymes.
Issues:  An elderly man with lethargy and tiredness who had normal free thyroid hormone T4, thyroid-stimulating hormone and a low T3 with subnormal temperature and low selenium level. Selenium supplementation normalised thyroid function tests.
Lessons learned:  Physicians should have high level of suspicion to identify selenium deficiency as an effective replacement will cure the causative disorder.


Australia, deiodinase, nutrition, selenium, thyroid, thyrotropin, thyroxine, triiodothyronine.

full article:


Selenium is a cofactor for glutathione peroxidase, deiodinases and thioredoxin reductases. Seletoxicity was recognised in the early part of the century; its role in mammalian physiology was identified in 19731. The importance of selenium in thyroid metabolism was not recognised until two decades ago2. The deiodinases are selenium dependent. These cofactors are essential for synthesis and peripheral conversion of T4 to T3 and rT3. We report here a case of selenium deficiency and improvement in thyroid functions after replacement.


Case report

A man aged 76 years was admitted with a history of falls, increasing confusion and spiking temperatures to Geraldton Regional Hospital in the mid-western region of Western Australia. His past medical history was significant for coronary heart disease, emphysema, aortic regurgitation, depression, epilepsy, diverticular disease, osteoarthritis and hearing impairment. He was allergic to roxithromycin. His drug history was sodium valproate 700 mg bd, prazocin 1 mg nocte, quetiapine 12.5 mg nocte, aspirin 100 mg od, atorvastatin 40 mg od, calcium carbonate 1.5 g with cholecalciferol 10 µg od and desvenlafaxine 50 mg MR od. Physical examination revealed a temperature of 38.7oC, respiratory rate 14 breaths per minute, oxygen saturation 98% on room air, blood pressure 114/70 mmHg and pulse rate of 72/minute regular. He had bradykinesia, cog-wheel rigidity, tremor and positive glabellar tap. Cardiopulmonary examination showed normal air entry, and an early diastolic murmur in the aortic area. Abdomen was soft and non-tender. Perianal abscess was present with tenderness and was discharging pus.

Even after the resolution of the infection with treatment, he continued to be unwell and lethargic. We noted subnormal temperatures on his daily vitals observation chart. Results of his investigations were as follows: haemoglobin 103 (range 135–180) g/L, white blood cell count 6.90×109 (range 4.00–11.00×109) /L, platelets 195×109 (range 150–400×109) /L. He manifested leucocytosis with high C-reactive protein, which normalised with antibiotics. Liver and renal function tests were normal.

Thyroid-stimulating hormone (TSH) was 1.40 (0.40–4.00) mU/L, free thyroid hormone T4 was 17 (range 9–19) pmol/L, free T3 <1.5 (range 3.0–5.5) pmol/L, selenium 0.6 (range 0.75–1.35) µmol/L. A CT scan showed involutional changes. A dilated aortic root, moderate aortic incompetence and ejection fraction of 55% were apparent on an echocardiogram. An electrocardiogram showed normal sinus rhythm and no evidence of ischaemia. Chest X-ray was normal, with a longstanding left hemi-diaphragmatic elevation.

Whenever thyroid function tests are abnormal in an admitted patient, the commonest diagnosis is sick euthyroid syndrome with low T3, normal T4 and normal or high TSH. In selenium deficiency, the conversion of T4 to T3 is impaired, giving rise to a low T3 and subtle features of hypothyroidism. The other condition with similar thyroid test results is selenium binding protein 2 deficiency, which is extremely rare and the selenium levels in this condition are much lower and thyroid functions do not respond to selenium supplementation.

Broad spectrum antibiotics and subsequent seton insertion led to complete resolution of infection. He acquired Clostridium difficile and thrush; these responded to metronidazole and amphoterecin lozenges respectively. As he also had clinical features diagnostic of Parkinson’s disease, levodopa/carbidopa 50/12.5 mg tds was commenced and he responded well to this. Selenium deficiency was treated with oral selenium 100 µg/d replacement. In view of the low temperature, lethargy and low selenium, he also received T3 10 µg/twice per day for 5 days. After supplementation his general condition improved with normalisation of body temperature.

Repeat thyroid function results 3 weeks later were as follows: TSH was 4.60 (range 0.40–4.00) mU/L, free T4 was 15 (range 9–19) pmol/L and free T3 was 3.6 (range 3.0–5.5) pmol/L. Clinically, he was much better with improved physical activity. Repeat thyroid function tests were normal. He was discharged to a nursing home. In view of his deteriorating general condition and frailty he and his family members opted for conservative management and he succumbed to a chest infection 8 months later.

Literature review

Selenium is a trace mineral discovered by Berzelius in Sweden in 1817. It has attained an essential nutrient status with Recommended Daily Intake of 70 µg/day for non-pregnant adults. Its deficiency was first recognised in the Chinese province of Keshan. Keshan disease is associated with cardiomyopathy and premature death. Low selenium levels are recorded in prostate, skin, pancreatic and various other cancers; however, supplementation and surveillance trials to prevent cancer were inconclusive. In areas with endemic cretinism in Zaire, selenium deficiency was seen along with iodine deficiency3. In these scenarios, supplementing selenium alone will not cure the disorder and may in fact exacerbate hypothyroidism.

The soil in the mid-western region of Western Australia is known for its richness in various minerals but parts are selenium deficient (Fig1)4. In Finland, when selenium deficiency was identified in livestock and humans, the fertilisers were fortified with selenium. Selenium entered the food chain of the livestock, which consequentially improved human selenium levels5. Similar data are available from Western Australia6. Nutritional data show a fall in population selenium levels when the UK switched from the selenium-rich North American wheat to imported selenium-poor wheat from Europe7. These observations confirm that soil mineral status affects the health of populations, and interventions in farming and agriculture benefit nutritional status. In animals, selenium deficiency leads to muscle disease, impaired growth and reduced fertility. Animal diets are supplemented or livestock given injections to overcome this. The biological importance was reflected in the outcome from the effective public health actions in Finland.

Seafood, meat and wheat are the common dietary sources of selenium in Western populations. Brazil nuts, grains and cereals are also good sources. Selenium is present in livestock feeds, fungicides and shampoos. Selenium applied topically is not absorbed. Selenium absorption in the gut is independent of the body selenium status7. It is not possible to quantify selenium in dietary assessment methods. Seletoxicity was reported even before the recognition of selenium as an essential element. Toxicity results in alopecia, nail dystrophy, nausea, vomiting and diarrhoea and neuropathy. The upper limit of intake for adults is 400 µg/day8 although selenium excretion is regulated by the kidneys. These limits are based on the physiological data from New Zealand9.

The selenoproteins of interest in the current context are iodothyronine deiodinases. When selenium deficiency occurs, an elevated free T4 with a low T3 and normal or high normal TSH is observed. In view of the immune susceptibility, various follow-up studies of selenium supplementation were conducted in euthyroid subjects. There is not sufficient evidence currently to support supplementation with selenium to prevent disease. A summary of these studies is reviewed elsewhere10-12. Recently, selenium deficiency was reported in a variety of clinical situations, including depression13, stereotypical features of disordered thinking14, clozapine-treated schizophrenic patients15, Graves’ disease16 and cot death17. An inverse correlation was noted between thyroid cancer and selenium levels in Norwegian epidemiological data18.

Thyroid is unique in many aspects, being the endocrine gland most affected by the autoimmune process. It generates the highest amount of free radicals per gram. Thyroid cells have low proliferative capacity and long half-lives. The thyroid follicular tissue is under constant oxidative stress from the reactive oxygen species in the high H2o2 milieu. It has the highest quantity of selenium content per gram of tissue, to protect the gland from free radical damage.

There are no characteristic clinical phenomena of selenium deficiency. This makes the identification of selenium deficiency difficult. Marginal selenium deficiency alone may not cause significant clinical disease. In Keshan disease, there was associated vitamin E deficiency and mutant Coxsackie strain infections. Currently, selenium supplements to humans are not recommended on a routine basis.

Two further cases of selenium deficiency were identified after this case. Scurvy was diagnosed in an elderly woman who had been previously investigated extensively at a tertiary centre for bleeding disorder19. Micronutrient and vitamin deficiencies constitute ‘hidden malnutrition’ in the developed world.

Figure 1:  Areas of selenium deficiency in Australia4

Lessons learned

Selenium is an essential micronutrient. A unique set of enzymes are selenium dependent and these include deiodinases. A high T4, low T3 and normal or high normal TSH with features of hypothyroidism should prompt the physician to check selenium levels. Physicians should be aware of trace mineral deficiencies as bedside presentations.


1 Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588-590. https://doi.org/10.1126/science.179.4073.588
2 Beckett GJ, Beddows SE, Morrice PC, Nicol F, Arthur JR. Hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochemical Journal 1987; 248: 443-447. https://doi.org/10.1042/bj2480443
3 Vanderpas JB, Contempre B, Duale, Deckx H, Bebe N, Longombe AO, et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. American Journal of Clinical Nutrition 1993; 57: 271s-275s. https://doi.org/10.1093/ajcn/57.2.271S
4 Judson GJ, Reuter DJ. Selenium. In: KI Peverill, LA Sparrow and DJ Reuter (Eds). Soil analysis: an interpretation manual. CSIRO Publishing. Collingwood, 1999; 325-329.
5 Varo P, Alfthan G, Varo P. Selenium. Effect of supplementation of fertilizers on human selenium status in Finland. Analyst 1995; 120: 841-843. https://doi.org/10.1039/an9952000841
6 Whelan BR, Barrow, NJ. Slow-release selenium fertilizers to correct selenium deficiency in grazing sheep in Western Australia. Fertilizer Research 1994; 38: 183-188. https://doi.org/10.1007/BF00749690
7 Burke RF, Levander OA. Selenium. In: ME Shills, M Shike, CA Ross, et al (Eds). Modern nutrition in health and disease. 10th edn. Philadelphia: Lippincott Williams and Wilkins. (2005): 312-325.
8 National Health and Medical Research Council and New Zealand Ministry of Health. Nutrient reference values for Australia and New Zealand. Available: http://www.nrv.gov.au/nutrients/selenium.htm (Accessed 1 March 2018).
9 Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. American Journal of Clinical Nutrition 1999; 70: 896-903. https://doi.org/10.1093/ajcn/70.5.896
10 Kohrle J, Gartner R. Selenium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism 2009; 23: 815-827. https://doi.org/10.1016/j.beem.2009.08.002
11 De Fusco C, Nettor CI, Colao A, Macchia PE. Selenium in the thyroid: physiology and pathology. Reviews in Endocrinology and Metabolism 2013; 1: 34-40. https://doi.org/10.11138/rem/2013.1.1.034
12 Duntas LH. Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology and Metabolism 2010; 95: 5180-5188. https://doi.org/10.1210/jc.2010-0191
13 Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz MA et al. Dietary selenium and major depression: a nested case-control study. Complementary Therapies in Medicine 2012; 20(3): 119-123. https://doi.org/10.1016/j.ctim.2011.12.008
14 Davies PI, Healey D, Davies EP, Green P. Selenium and stereotypies in mental health. BMJ Case Reports 2009. https://doi.org/10.1136/bcr.07.2009.2053
15 Vaddadi KS, Soosai E, Vaddadi G. Low blood selenium concentrations in schizophrenic patients on clozapine. British Journal of Clinical Pharmacology 2003; 55: 307-309. https://doi.org/10.1046/j.1365-2125.2003.01773.x
16 Khong JJ, Goldstein RF, Sanders KM, Schneider H, Pope J, Burdon KP, et al. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Clinical Endocrinology (Oxford) 2014; 80: 905-910. https://doi.org/10.1111/cen.12392
17 McGlashan ND. Low selenium status and cot deaths. Medical Hypotheses 1991; 35: 311-314. https://doi.org/10.1016/0306-9877(91)90274-3
18 Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Science of the Total Environment 1993; 139: 527-535. https://doi.org/10.1016/0048-9697(93)90049-C
19 Ghumman A, Thwin N, Kodali VRR. Forgotten nutritional disorder in an elderly woman. Journal of Gerontology and Geriatrics Research 2014; 3: 190. https://doi.org/10.4172/2167-7182.1000190